ReportsnReports.com adds Global Womens Health Market 2016-2020 latest research report, the limited funding for public health clinics globally has led to a rise in common STIs such as chlamydia, syphilis, and gonorrhea. Such diseases should be treated urgently as they can cause pelvic inflammatory diseases, stillbirths, neonatal infections, and infertility. Various public health institutes highly recommend that women who are sexually active must undergo STI screening once a year. The increase in detections of STIs will positively affect this market. The analysts forecast global women's health market to grow at a CAGR of 3.84% during the period 2016-2020.
View Womens Health market complete report at http://www.reportsnreports.com/reports/533921-global-womens-health-market-2016-2020.html
According to the womens health market report, the rise in the number of older women worldwide has spurred the market, with companies investing in R&D to develop new women's health solutions to enhance their existing portfolio. Many of the diseases women are diagnosed with are associated with old age. This will fuel the growth of the women's health market over the forecast period.
Segmentation by application and analysis of women’s health market
Polycystic ovary syndrome
During 2015, the postmenopausal osteoporosis segment dominated the market and accounted for more than 37% of the market share. Factors such as the rising number of older people worldwide. Women above 50 are likely to be affected with postmenopausal symptoms due to various hormonal changes. According to the International Osteoporosis Foundation, it is expected that close to 200 million women will be affected by postmenopausal osteoporosis globally, thereby spurring the growth of this market segment over the forecast period.
Check for DISCOUNT at @ http://www.reportsnreports.com/contacts/Discount.aspx?name=533921
In 2015, the global women’s heath market was led by the Americas accounting for close to 40% of the market share. The region is exhibiting consistent growth because of the increasing population of older women affected by diseases such as breast cancer, endometriosis, and postmenopausal osteoporosis. Moreover, the presence of several labs and research facilities in the region will also drive this market’s growth in the Americas.
The global women’s health market is highly fragmented and is characterized by the presence of several international and regional vendors. The vendors in this market compete in terms of price, quality, product differentiation, distribution, and promotion to gain maximum market prominence during the forecast period. The competitive environment is likely to intensify with an increase in product or service extensions, product innovations, and M&A.
Order a copy of Global Womens Health Market 2016-2020 report @ http://www.reportsnreports.com/Purchase.aspx?name=533921
Key players in the global womens health market: Allergan, Bayer HealthCare, Merck, Pfizer, and Teva Pharmaceuticals.
Other prominent vendors in the market are: Agile Therapeutics, Amgen, Apothecus Pharmaceutical, AstraZeneca, Blairex Laboratories, Bristol-Myers Squibb, EffRx, Ferring International Center, GlaxoSmithKline, HLL Lifecare, Janssen Pharmaceutical, Lipocine, Ligand Pharmaceuticals, Lupin Pharmaceuticals, Mayer Laboratories, Medicines 360, Neurocrine Biosciences, Novartis, Novo Nordisk, Pantarhei Bioscience, and Sanofi.
ReportsnReports.com is your single source for all market research needs. Our database includes 500,000+ market research reports from over 95 leading global publishers & in-depth market research studies of over 5000 micro markets. With comprehensive information about the publishers and the industries for which they publish market research reports, we help you in your purchase decision by mapping your information needs with our huge collection of reports.
Connect With Us on:
Twitter: https: //twitter.com/marketsreports
G+ / Google Plus: https://plus.google.com/111656568937629536321/posts
P: + 1 888 391 5441